A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ESFTs
Long Form : Ewing sarcoma family of tumors
No. Year Title Co-occurring Abbreviation
2019 A case of Ewing sarcoma family tumor of the kidney treated with robotic-assisted partial nephrectomy. RCC
2019 Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients. CAR, DFS, OS
2019 Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma. CCLE, CNVs, CTRP, DGV, GEO, OS, RMS
2019 Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors. NSE, ProGRP
2018 Antitumor effects of beta-elemene via targeting the phosphorylation of insulin receptor. IGF1R, IR
2018 Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches. ES, PNETs, SEER
2018 Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. CT, DOR, F-FDG, PET, SROC
2018 Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors. EVs
2018 Primary orbital Ewing sarcoma family of tumors: a study of 12 cases. ---
10  2017 Cytogenetically confirmed primary Ewing's sarcoma of the pancreas. ---
11  2017 Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center. OS, RFS
12  2016 PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways. IR, PRAS40, TUNEL
13  2015 IDH Mutation Analysis in Ewing Sarcoma Family Tumors. alpha-KG, IDH
14  2015 Surgically treated patients with axial and peripheral Ewing's sarcoma family of tumours: A population based study in Finland during 1990-2009. ---
15  2014 EWS represses cofilin 1 expression by inducing nuclear retention of cofilin 1 mRNA. CFL1, ETS, FLI1
16  2014 EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model. ---
17  2014 Imaging findings of the spinal peripheral Ewing's sarcoma family of tumours. MRI
18  2013 Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors. ---
19  2013 Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study. ---
20  2013 Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma. Gal-1
21  2013 Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. ---
22  2013 Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4-year-old girl. VDC/IE
23  2012 A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis. PNETs
24  2012 Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance? EMT, OS, PFS
25  2011 BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma. YAP
26  2011 Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. ---
27  2011 High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients. ---
28  2011 Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. CI
29  2011 The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors. cPNETs, FISH
30  2010 Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. COG, EFS, OS, RT-PCR
31  2010 EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. CSCs, ESC, hpMSCs, miRNA-145, MSC
32  2010 Results of RS-99 protocol for childhood solid tumors. AVCP, EFS, GCTs, RMSs
33  2010 Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesu Children's Hospital. ETC, HDC
34  2009 A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. RHA
35  2009 Ewing's sarcoma family tumors mimicking primary central nervous system neoplasms. PNETs
36  2009 Ewing's sarcoma family tumors of the humerus: outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy. ---
37  2009 Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. FISH, IHC, RT-PCR, SRCTs, TMAs
38  2009 O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. ---
39  2009 Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours. CA4P, VDAs
40  2007 Concurrent Ewing sarcoma family of tumors and fibrous dysplasia: possible diagnostic pitfall. FD
41  2007 Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. EFS, SE
42  2005 [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. FDG, PET, PFS
43  2002 Ewing sarcoma family of tumors express adenovirus receptors and are susceptible to adenovirus-mediated oncolysis. Ad, CAR
44  2001 Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. DRs, FLIP, TRAIL
45  2001 Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors. IGF-1, IGF-1R, IGFBP-3
46  1999 Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors. IGF-IR, PI 3-K